Patents Represented by Attorney Anita W. Magatti
  • Patent number: 4540580
    Abstract: Disclosed are 6-(1'-hydroxyethyl)-2-[(1'R)-1'-aminoalkyl]penem-3-carboxylic acids and salts and esters thereof. The compounds are useful and potent antibacterial agents and can be formulated into a variety of forms suitable for oral, parenteral or topical use.
    Type: Grant
    Filed: November 16, 1982
    Date of Patent: September 10, 1985
    Assignee: Schering Corporation
    Inventors: Adriano Afonso, Jay Weinstein
  • Patent number: 4530793
    Abstract: Processes for the production of 6-hydroxyethyl-2-substituted thio penem-3-carboxylates are disclosed as well as novel penems.
    Type: Grant
    Filed: November 29, 1982
    Date of Patent: July 23, 1985
    Assignee: Schering Corporation
    Inventors: Viyyoor M. Girijavallabhan, Ashit K. Ganguly, Patrick A. Pinto, Richard W. Versace
  • Patent number: 4528291
    Abstract: The pyridinyl-thiazole derivatives of the present invention exhibit good cardiotonic activity.
    Type: Grant
    Filed: June 22, 1982
    Date of Patent: July 9, 1985
    Assignee: Schering Corporation
    Inventors: Joseph T. Witkowski, Brooks R. Sunday
  • Patent number: 4512998
    Abstract: Compounds of the formula ##STR1## wherein R is alkyl having 1 to 4 carbon atoms, one of Y and Z is a heterocyclic moiety, and the other of Y and Z is hydrogen, alkyl having 1 to 4 carbon atoms or alkoxy having 1 to 4 carbon atoms are useful as anthelmintics.
    Type: Grant
    Filed: October 20, 1980
    Date of Patent: April 23, 1985
    Assignee: Schering Corporation
    Inventor: M.Mehdi Nafissi-Varchei
  • Patent number: 4511569
    Abstract: Disclosed are 5,6-dihydro benzo[f]quinolines and derivatives which are effective in increasing cardiac contractility. These compounds are useful in the treatment of congestive heart failure.
    Type: Grant
    Filed: August 26, 1982
    Date of Patent: April 16, 1985
    Assignee: Schering Corporation
    Inventors: Elizabeth M. Smith, Ronald J. Doll, Bernard R. Neustadt
  • Patent number: 4482564
    Abstract: Disclosed are triazolyl-substituted propane derivatives useful in the treatment of fungal diseases of humans and animals. Also disclosed are the processes for preparing the compounds, pharmaceutical compositions containing them, and the method of treating fungal diseases with said compounds.
    Type: Grant
    Filed: June 3, 1983
    Date of Patent: November 13, 1984
    Assignee: Schering Corporation
    Inventors: John J. Wright, Alan B. Cooper
  • Patent number: 4474786
    Abstract: Disclosed are tricyclic lactams and derivatives which are effective in increasing cardiac contractility in humans. These compounds are useful in the treatment of congestive heart failure.
    Type: Grant
    Filed: June 16, 1983
    Date of Patent: October 2, 1984
    Assignee: Schering Corporation
    Inventors: Elizabeth M. Smith, Ronald J. Doll, Bernard R. Neustadt
  • Patent number: 4472393
    Abstract: This invention relates to novel 3,20-dioxo-1,4-pregnadiene-17.alpha.-ol 17-aromatic heterocyclic carboxylates, to pharmaceutical formulations thereof, and their use in the treatment and control of inflammatory conditions.
    Type: Grant
    Filed: July 29, 1982
    Date of Patent: September 18, 1984
    Assignee: Schering Corporation
    Inventor: Elliot L. Shapiro
  • Patent number: 4468396
    Abstract: This invention relates to benzothiadiazinyl-substituted carboxyalkyl dipeptides useful as combined antihypertensive and diuretic agents.
    Type: Grant
    Filed: December 20, 1982
    Date of Patent: August 28, 1984
    Assignee: Schering Corporation
    Inventor: Charles V. Magatti
  • Patent number: 4468404
    Abstract: 3-Aralkyloxy-2,3-dihydro-2-(triazolylmethyl)benzo(b)thiophenes and related derivatives having antifungal, antibacterial, and antiprotozoal activity are prepared by the reaction of the corresponding 2,3-dihydro-3-hydroxy-2-(triazolylmethyl)benzo(b)thiophene or related derivative and an aralkyl halide.Preferred compounds are those where the aralkyl function is a hetercyclic aromatic, particularly 2-chloro-3-thenyl, and where the benzene nucleus is substituted by chlorine or fluorine.Pharmaceutical formulations comprising compounds of this invention are described, as well as the method for their use in treating microbial infections.
    Type: Grant
    Filed: July 29, 1982
    Date of Patent: August 28, 1984
    Assignee: Schering Corporation
    Inventors: Dinanath F. Rane, John J. Wright, Russell E. Pike
  • Patent number: 4450164
    Abstract: This invention relates to imidazo[1,2-a]pyridine derivatives which are useful in the treatment of peptic ulcer diseases.
    Type: Grant
    Filed: December 20, 1982
    Date of Patent: May 22, 1984
    Assignee: Schering Corporation
    Inventors: James A. Bristol, Chester Puchalski
  • Patent number: 4448782
    Abstract: 6-Substituted-hydrocarbon-2-(amino acid-thio)penem-3-carboxylic acids and congeners having useful antibacterial activity are disclosed. The compounds are prepared in a reaction sequence starting with a 4-acyloxy-2-azetidinone.
    Type: Grant
    Filed: October 30, 1981
    Date of Patent: May 15, 1984
    Assignee: Schering Corporation
    Inventor: Adriano Afonso
  • Patent number: 4443463
    Abstract: Sodium, Potassium, Phthalidyl and Pivalyloxymethyl (5R,6S,8R)-6-(1-hydroxyethyl)-2-(2-hydroxyethylthio)-penem-3-carboxylates exhibit potent, broad spectrum antibacterial activity, are orally effective and chemically stable.
    Type: Grant
    Filed: November 25, 1981
    Date of Patent: April 17, 1984
    Assignee: Schering Corporation
    Inventor: Stuart W. McCombie
  • Patent number: 4443373
    Abstract: There is disclosed a process for preparing 6-hydroxyethyl-2-alkylthio penem-3-carboxylates by a multi-step process comprising reacting an azetidinone having a protected hydroxy group at the 5 position with a diester of ketomalonic acid, chlorinating the resulting N-substituted azetidinone, removing the chlorine and OH protecting group, reacting the resulting compound with a silver salt to form a silver thio substituted at the 4 position of the azetidinone, cyclizing with a thiocarbonyl compound, then reacting the resulting penam with a fluoride to form a penam-penem tautomer, reacting the tautomer with a halide or ethylenically unsaturated compound followed by deprotecting the carboxyl at the 3 position to form the final penem product in high yield.
    Type: Grant
    Filed: March 30, 1982
    Date of Patent: April 17, 1984
    Assignee: Schering Corporation
    Inventors: Viyyoor M. Girijavallabhan, Ashit K. Ganguly, Patrick A. Pinto, Richard W. Versace
  • Patent number: 4440751
    Abstract: The novel antibiotic complex designated hazymicin consisting of eight components, is produced by a novel strain of Micromonospora herein designated Micromonospora echinospora var. challisensis SCC 1411. Also disclosed are the structures of the two components namely, Component 5 and Component 6.
    Type: Grant
    Filed: October 6, 1980
    Date of Patent: April 3, 1984
    Assignee: Schering Corporation
    Inventors: Jay A. Waitz, Joseph A. Marquez, Mahesh G. Patel, Ann C. Horan
  • Patent number: 4436729
    Abstract: There are disclosed novel 23-demycinosyltylosin and derivatives thereof which have improved activity as antibiotics. Methods of preparation of the compounds are also disclosed.
    Type: Grant
    Filed: June 30, 1982
    Date of Patent: March 13, 1984
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Yi-Tsung Liu, Alan K. Mallams
  • Patent number: 4435398
    Abstract: Compounds of the formula ##STR1## and their pharmaceutically acceptable acid addition salts are disclosed. The compounds are useful as anthelmintics.
    Type: Grant
    Filed: February 8, 1982
    Date of Patent: March 6, 1984
    Assignee: Schering Corporation
    Inventor: M. Mehdi Nafissi-Varchei
  • Patent number: 4435388
    Abstract: There are disclosed 20-imino-20-deoxo-4"-acyl derivatives of the antibiotic tylosin which have higher serum levels and better absorption than the parent tylosins. Methods of preparation of the compounds are also disclosed.
    Type: Grant
    Filed: June 10, 1982
    Date of Patent: March 6, 1984
    Assignee: Schering Corporation
    Inventors: Ashit K. Ganguly, Allan K. Mallams, Yi-Tsung Liu
  • Patent number: 4431816
    Abstract: This invention relates to 2,3-dihydro-2-(imidazolylmethyl)benzo(b)thiophenes, to intermediates useful in their preparation, and to processes for preparing said intermediates. Also included in the invention are pharmaceutical compositions and the method of use of the compounds as antifungal agents.
    Type: Grant
    Filed: March 3, 1982
    Date of Patent: February 14, 1984
    Assignee: Schering Corporation
    Inventors: Dinanath F. Rane, John J. Wright, Russell E. Pike
  • Patent number: 4431645
    Abstract: Compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently selected from hydrogen or lower alkyl; n is 1 or 0; A and B taken together with the carbons to which they are attached form an alkylene ring having six carbon atoms or A and B are hydrogen; and Z is ##STR2## The compounds are useful as hypertensive agents.
    Type: Grant
    Filed: March 8, 1982
    Date of Patent: February 14, 1984
    Assignee: Schering Corporation
    Inventors: Elizabeth M. Smith, Joseph T. Witkowski